Cancer stem cells in prostate cancer: implications for targeted therapy

Prostate cancer (PCa) is the most frequently diagnosed cancer in men and the second most common cause of cancer-related mortality among men in the developed world. Conventional anti-PCa therapies include surgery, radiation, hormonal ablation, and chemotherapy. Despite increasing efforts, these thera...

ver descrição completa

Detalhes bibliográficos
Autor principal: Leao, Ricardo (author)
Outros Autores: Domingos, Célia (author), Figueiredo, Arnaldo (author), Hamilton, Robert (author), Tabori, Uri (author), Castelo-Branco, Pedro (author)
Formato: article
Idioma:eng
Publicado em: 2018
Assuntos:
Epithelial mesenchymal transition
Stem progenitor cells
Signaling pathway
Rat prostate
Differentiation pathways
Monoclonal antibodies
Keratin expression
Androgen receptor
Initiating cells
Drug resistance
Texto completo:http://hdl.handle.net/10400.1/11996
País:Portugal
Oai:oai:sapientia.ualg.pt:10400.1/11996

Texto Completo

http://hdl.handle.net/10400.1/11996

Registos relacionados